Tobam Charles River Laboratories International, Inc. Transaction History

Tobam

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$194.44 - $217.61 $41,804 - $46,786	-215 Reduced 44.06%	273 $54,000
Q2 2023 Jul 31, 2023	BUY	$183.71 - $210.25 $89,650 - $102,602	488 New	488 $103,000
Q4 2022 Feb 02, 2023	BUY	$197.11 - $250.07 $59,133 - $75,021	300 Added 204.08%	447 $97,000
Q3 2022 Nov 02, 2022	SELL	$182.44 - $250.54 $18,973 - $26,056	-104 Reduced 41.43%	147 $29,000
Q1 2022 Apr 25, 2022	BUY	$255.51 - $362.11 $64,133 - $90,889	251 New	251 $71,000

696

51.8M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.33B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.